GEODE CAPITAL MANAGEMENT, LLC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1214717 BOSTON, MA

Back to SUPN Full portfolio

Position in SUPN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$83,919,437

+$10,716,357 QoQ

Shares Held

1,623,514

+10.2% QoQ

Ownership

2.80%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $4,626,668,708 across 67 Drug Manufacturers - Specialty & Generic names. SUPN ranks #12 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	11,349,248	$1,341,594,605
2	UTHR	UNITED THERAPEUTICS Corp	1,233,029	$731,161,535
3	VTRS	Viatris Inc	31,846,107	$430,240,905
4	TEVA	Teva Pharmaceutical Industries Ltd	10,564,988	$318,217,437
5	NBIX	Neurocrine Biosciences Inc	2,136,672	$281,485,168
6	ELAN	Elanco Animal Health Inc	11,192,404	$267,834,227
7	ALKS	Alkermes plc.	4,182,267	$147,884,960
8	LNTH	Lantheus Holdings, Inc.	1,765,952	$133,947,458

All Filings in SUPN

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$83,919,437	1,623,514	+10.2%	Shares	Defined	2026-05-15
2025-12-31	$73,203,080	1,472,899	+4.5%	Shares	Defined	2026-02-09
2025-09-30	$67,385,046	1,410,024	+0.7%	Shares	Defined	2025-11-12
2025-06-30	$44,115,706	1,399,610	+5.5%	Shares	Defined	2025-08-08
2025-03-31	$43,446,772	1,326,619	-12.2%	Shares	Defined	2025-05-13
2024-12-31	$54,622,138	1,510,568	+1.9%	Shares	Defined	2025-02-12
2024-09-30	$46,210,350	1,482,051	+5.3%	Shares	Defined	2024-11-12
2024-06-30	$37,653,647	1,407,613	+7.7%	Shares	Defined	2024-08-09
2024-03-31	$44,580,064	1,306,950	+5.0%	Shares	Defined	2024-05-13
2023-12-31	$36,034,756	1,245,154	+13.9%	Shares	Defined	2024-02-13
2023-09-30	$30,136,684	1,093,097	+3.7%	Shares	Defined	2023-11-13
2023-06-30	$31,687,628	1,054,146	+1.6%	Shares	Defined	2023-08-11
2023-03-31	$37,588,371	1,037,493	+3.1%	Shares	Defined	2023-05-15
2022-12-31	$35,903,531	1,006,547	+6.1%	Shares	Defined	2023-02-13
2022-09-30	$32,120,603	948,910	+1.0%	Shares	Defined	2022-11-14
2022-06-30	$27,159,957	939,141	+1.0%	Shares	Defined	2022-08-12
2022-03-31	$30,057,826	930,007	-3.3%	Shares	Defined	2022-05-13
2021-12-31	$28,043,405	961,708	+1.3%	Shares	Defined	2022-02-11
2021-09-30	$25,310,176	949,013	+4.8%	Shares	Defined	2021-11-12
2021-06-30	$27,886,225	905,691	+4.1%	Shares	Defined	2021-08-13
2021-03-31	$22,766,756	869,624	+9.3%	Shares	Defined	2021-05-12
2020-12-31	$20,013,043	795,431	+4.2%	Shares	Defined	2021-02-12
2020-09-30	$15,902,128	763,058	-1.3%	Shares	Defined	2020-11-13
2020-06-30	$18,356,541	772,907	+1.9%	Shares	Defined	2020-08-13
2020-03-31	$13,642,590	758,343	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.